ADHD; Resilience; StressNCT05620745
Comparison of Resilience Between ADHD and Controls.
An observational study of ADHD; Resilience; Stress, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
Trial summary
To explore if resilience serves as a mediator between adverse life events and emotional and behavioral problems, and compare the difference of resilience and its mediating effects between children and adolescents with and without ADHD. Read more about this study
- Who is it for?
- Ages 6 to 18 years
- Conditions the study is for
- ADHD; Resilience; Stress
- How many people
- 400 participants
- Where
- 1 siteTaiwan
- Study dates
- 1 Oct 2022to 1 Nov 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 18 years
- All sexes
- Child, Adult
Study population: cases ever diagnosed as ADHD; Controls who didn't recieve ADHD diganosis before.
Who may be able to join
- ADHD; Control without ADHD
Who cannot join
- ASD, other major physical and psychiatric diseases
Trial locations and contacts
1 site in 1 country.
Taiwan1 site, 1 recruiting
- Recruiting
Chang Gung memorial hospital
Taoyuan City
Hsiang Lin Chan, MD, +886 033281200 ext. 3824, ivyhlin70@kimo.com
About this study
Official title: Resilience as a Mediator Between Adverse Life Events and Emotional Behavioral Problems in Children and Adolescents and Comparison Between Individuals With Attention-Deficit /Hyperactive Disorder and Controls
To explore if resilience serves as a mediator between adverse life events and emotional and behavioral problems, and compare the difference of resilience and its mediating effects between children and adolescents with and without ADHD.
- Conditions
- ADHD; Resilience; Stress
- Medical subject headings
- Attention Deficit Disorder with Hyperactivity
What is being measured
The primary outcome is the main question the study is designed to answer.
comparison of resilience between ADHD and controls
We will use SPSS and SPSS PROCESS to analyze the data. The t-test will be used to compare the difference of resilience performance between child and adolescents with and without ADHD.
Pearson correlation analyses will be adopted to calculate the relationships between all variables.
Moreover, the bias-corrected method was used to estimate the 95% bootstrap confidence interval (CI)of the mediating and moderating effects of resilience between adverse life events and emotional and behavioral problems. Finally, we would compare if there is difference between the mediating effect of resilience in group with ADHD and control group.
Measured: up to 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Nov 2022
- Study start1 Oct 2022
- Primary completion1 Oct 2023 (estimated)
- Study completion1 Nov 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ADHD; Resilience; StressStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05620745
- Sponsor's protocol ID
- CMRPG3M1351
- Status last verified
- Oct 2022
- First submitted
- 26 Oct 2022
- Last updated
- 17 Nov 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Resilience as a Mediator Between Adverse Life Events and Emotional Behavioral Problems in Children and Adolescents and Comparison Between Individuals With Attention-Deficit /Hyperactive Disorder and Controls
- ClinicalTrials.gov ID
- NCT05620745
- Acronym / sponsor ID
- CMRPG3M1351
- Conditions
- ADHD; Resilience; Stress
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Chang Gung Memorial HospitalUniversity, hospital or other
- Study start
- 1 Oct 2022 (actual)
- Primary completion
- 1 Oct 2023 (estimated)
- Study completion
- 1 Nov 2023 (estimated)
- First posted
- 17 Nov 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To explore if resilience serves as a mediator between adverse life events and emotional and behavioral problems, and compare the difference of resilience and its mediating effects between children and adolescents with and without ADHD.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 6 to 18 years
- Sex
- All
- Age groups
- Child, Adult
- Study population
- cases ever diagnosed as ADHD; Controls who didn't recieve ADHD diganosis before.
Key inclusion criteria (1 listed)
- ADHD; Control without ADHD
Key exclusion criteria (1 listed)
- ASD, other major physical and psychiatric diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
comparison of resilience between ADHD and controls
Time frame: up to 1 month
We will use SPSS and SPSS PROCESS to analyze the data. The t-test will be used to compare the difference of resilience performance between child and adolescents with and without ADHD. Pearson correlation analyses will be adopted to calculate the relationships between all variables. Moreover, the bias-corrected method was used to estimate the 95% bootstrap confidence interval (CI)of the mediating and moderating effects of resilience between adverse life events and emotional and behavioral problems. Finally, we would compare if there is difference between the mediating effect of resilience in group with ADHD and control group.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Nov 2022.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of ADHD; Resilience; Stress, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hsiang Lin Chan, MD (886 033281200 ext. 3824, 8802038@adm.cgmh.org.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
comparison of resilience between ADHD and controls (time frame: up to 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2022; AzTrials last refreshed its copy on 1 Nov 2026.